GABAergic mechanisms in epilepsy

Epilepsia

Volumn 42, Issue SUPPL. 3, 2001, Pages 8-12

  Treiman, David M ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

Antiepileptic drug; GABA; Model; Neurotransmitters; Seizures

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; BENZODIAZEPINE DERIVATIVE; CALCIUM ION; GABOXADOL; GLUTAMATE DECARBOXYLASE; MUSCIMOL; POTASSIUM ION; PROGABIDE; TIAGABINE; VIGABATRIN;

BRAIN LEVEL; CALCIUM TRANSPORT; CEREBROSPINAL FLUID ANALYSIS; CONFERENCE PAPER; DISEASE MODEL; EPILEPSY; EPILEPTOGENESIS; GABAERGIC SYSTEM; HUMAN; NEUROTRANSMITTER RELEASE; NEUROTRANSMITTER UPTAKE; NONHUMAN; POSTSYNAPTIC POTENTIAL; POTASSIUM CONDUCTANCE; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN BINDING;

4-AMINOBUTYRATE TRANSAMINASE; ANIMALS; DISEASE MODELS, ANIMAL; EPILEPSY; GABA AGONISTS; GABA ANTAGONISTS; GAMMA-AMINOBUTYRIC ACID; HUMANS; MICE; MODELS, GENETIC; RATS;

EID: 0034865645     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2001.042Suppl.3008.x     Document Type: Conference Paper

References (38)

1. A receptor-gated ion channel: Biochemical and pharmacological studies of structure and function
2. A-receptor subtypes really occur in the brain?
3. Baclofen suppresses hippocampal epileptiform activity at low concentrations without suppressing synaptic transmission
4. Baclofen has a proepileptic effect in the rat dentate gyrus
5. GABA and epileptogenesis
6. Benzodiazepine/gamma-aminobutyric acid receptor deficit in the midbrain of the seizure-susceptible gerbil
7. Gamma-aminobutyric acid and benzodiazepine binding sites in audiogenic seizure-susceptible mice
8. Midbrain GABA receptor deficit in genetic animal models of epilepsy
9. VIP-, SS-, and GABA-like immunore-activity in the mid-hippocampal region of El (epileptic) and C57BL/6 mice
10. Increased numbers of GABAergic neurons occur in the inferior colliculus of an audiogenic model of genetic epilepsy
11. A regional increase in the number of hippocampal GABAergic neurons and terminals in the seizure-sensitive gerbil
12. Amino acid and monoamine metabolite levels in CSF of Papio papio: Correlation with photosensitive response
13. Changes in GABA-immunoreactive cell density during motor focal epilepsy induced by cobalt in the rat
14. Inhibitory, GABAergic nerve terminals decrease at sites of focal epilepsy
15. Time course of the reduction of GABA terminals in a model of focal epilepsy: A glutamic acid decarboxylase immunocytochemical study
16. Altered excitatory and inhibitory amino acid receptor binding in hippocampus of patients with temporal lobe epilepsy
17. "Central" and "peripheral" benzodiazepine receptors: Opposite changes in human epileptogenic tissue
18. GABA/benzodiazepine receptors in human focal epilepsy
19. In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci
20. In vivo cerebral metabolism and central benzodiazepine- receptor binding in temporal lobe epilepsy
21. Biochemical evidence for dysfunction of GABA neurons in human epilepsy
22. Altered patterns of dynorphin immunoreactivity suggest mossy fiber reorganization in human hippocampal epilepsy
23. Granule cell disorganization in the dentate gyrus: Possible alterations of neuronal migration in human temporal lobe epilepsy
24. Glutamate decarboxylase-immunoreactive neurons are preserved in human epileptic hippocampus
25. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain
26. Hippocampal GABA transporter function in temporal-lobe epilepsy
27. Mechanisms of anticonvulsant drug action
28. Electrophysiological pharmacology of GABA and diazepam in cultured CNS neurons
29. Diazepam and (-)-pentobarbital: Fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons
30. Multicenter dose-response study of vigabatrin in adults with focal (partial) epilepsy
31. Effects of vigabatrin on partial seizures and cognitive function
32. A double-blind, placebo-controlled crossover study of vigabatrin 2 g/day and 3 g/day in uncontrolled partial seizures
33. A double-blind, placebo-controlled study of vigabatrin three g/day in patients with uncontrolled complex partial seizures
34. Adjunctive treatment of partial seizures with tiagabine: A placebo-controlled trial
35. International experience with tiagabine add-on therapy
36. Tiagabine therapy for complex partial seizures: A dose-frequency study: The Tiagabine Study Group
37. Tiagabine for complex partial seizures: A randomized, add-on, dose-response trial
38. A review of the preclinical pharmacology of tiagabine: A potent and selective anticonvulsant GABA uptake inhibitor